Current Products In Development

1. Facial analysis AI for early detection of genetic syndromes

This asset uses advanced computer vision models to analyze facial images and highlight phenotypic patterns associated with specific genetic syndromes. The goal is to support earlier identification and referral of patients who may benefit from confirmatory testing and specialized care. We are training and validating the models on curated datasets in collaboration with clinical partners.

2. Precision-care management concept asset (under development)

This is a early-stage AI asset currently under development. The intent is to create a longitudinal precision-care management capability. This would combine risk stratification logic, care-pathway frameworks, and patient engagement workflows to support management of genetically influenced conditions.

3. Neurology-focused screening & pathways concept asset (under development)

This is a proposed AI asset focused on neurologic conditions with high unmet need and suspected or confirmed genetic components. The capability is to provide AI-supported screening, risk stratification, and pathway suggestions using clinical history, imaging, and related data.

4. Prenatal decision support concept asset (under development)

The intended direction for this application is to explore prenatal decision support using imaging, maternal history, and, where applicable, genetic testing inputs to suggest guideline-aligned next steps.

5. Adult-onset risk triage & guidance concept asset (under development)

This application is aimed at adult-onset conditions where genetic or polygenic risk may be clinically relevant. The envisioned capability is to support risk-based triage and guidance using risk scores, family history, and clinical features.

6. Carrier status & family-planning pathways concept asset (under development)

This application will support individuals and couples who receive carrier status results. The intended design is to structure risk information, align options with guidelines, and map patients into appropriate counseling and reproductive services.

7. Trial-enrichment & registry SDK concept asset (under development)

This application is an SDK/API asset that is currently under development. The goal is to expose risk and pathway logic for potential use in trial enrichment, registry design, and post-market follow-up in collaboration with biopharma.

8. Tele-genetics consult funnel & partner network concept asset (under development)

Application aimed to coordinate a tele-genetics consult funnel and partner network. The envisioned capability is to route patients identified into appropriate genetic counseling, specialty consults, and testing partners.

All AI assets described on this page are in various stages of internal research and development. They are not cleared, approved, or validated for clinical use and are not currently available as commercial products.